| [1] |
Jiang JY, Gao GY, Feng JF, et al. Traumatic brain injury in China[J]. Lancet Neurol, 2019, 18(3): 286-295.
|
| [2] |
邹隽风，黄贤键，吴楚伟,等.中国颅脑创伤流行病学中存在的部分问题探讨[J].中华神经创伤外科电子杂志, 2021, 7(1): 59-62.
|
| [3] |
Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets[J]. Front Cell Neurosci, 2019, 13: 528.
|
| [4] |
Rebeck GW. The role of APOE on lipid homeostasis and inflammation in normal brains[J]. J Lipid Res, 2017, 58(8): 1493-1499.
|
| [5] |
Chen Y, Strickland MR, Soranno A, et al. Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis[J]. Neuron, 2021, 109(2): 205-221.
|
| [6] |
Choudhury P, Ramanan VK, Boeve BF. APOE ɛ4 allele testing and risk of Alzheimer disease[J]. JAMA, 2021, 325(5): 484-485.
|
| [7] |
Jiang Y, Sun X, Xia Y, et al. Effect of APOE polymorphisms on early responses to traumatic brain injury[J]. Neurosci Lett, 2006, 408(2): 155-158.
|
| [8] |
Flowers SA, Rebeck GW. APOE in the normal brain[J]. Neurobiol Dis, 2020, 136: 104724.
|
| [9] |
Sun Y, Wu S, Bu G, et al. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins[J]. J Neurosci, 1998, 18(9): 3261-3272.
|
| [10] |
Laskowitz DT, Fillit H, Yeung N, et al. Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease[J]. Acta Neurol Scand Suppl, 2006, 185: 15-20.
|
| [11] |
吴海涛，江涌，张晓冬,等.载脂蛋白E基因多态性影响星形胶质细胞损伤后早期NF-κB表达的实验研究[J].第三军医大学学报, 2010, 32(2): 103-106.
|
| [12] |
Laurat E, Poirier B, Tupin E, et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice[J]. Circulation, 2001, 104(2): 197-202.
|
| [13] |
James ML, Komisarow JM, Wang H, et al. Therapeutic development of apolipoprotein E mimetics for acute brain injury: augmenting endogenous responses to reduce secondary injury[J]. Neurotherapeutics, 2020, 17(2): 475-483.
|
| [14] |
Muza P, Bachmeier C, Mouzon B, et al. APOE genotype specific effects on the early neurodegenerative sequelae following chronic repeated mild traumatic brain injury[J]. Neuroscience, 2019, 404: 297-313.
|
| [15] |
Main BS, Villapol S, Sloley SS, et al. Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury[J]. Mol Neurodegener, 2018, 13(1): 17.
|
| [16] |
Teng Z, Guo Z, Zhong J, et al. ApoE influences the blood-brain barrier through the NF-κB/MMP-9 pathway after traumatic brain injury[J]. Sci Rep, 2017, 7(1): 6649.
|
| [17] |
Huang YA, Zhou B, Wernig M, et al. ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and Aβ Secretion[J]. Cell, 2017, 168(3): 427-441.e21.
|
| [18] |
Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders[J]. Neuron, 2008, 57(2): 178-201.
|
| [19] |
Chen XH, Johnson VE, Uryu K, et al. A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury[J]. Brain Pathol, 2009, 19(2): 214-223.
|
| [20] |
Bell RD, Sagare AP, Friedman AE, et al. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system[J]. J Cereb Blood Flow Metab, 2007, 27(5): 909-918.
|
| [21] |
Rodriguez-Vieitez E, Nielsen HM. Associations between APOE variants, tau and alpha-synuclein [J]. Adv Exp Med Biol, 2019, 1184:177-186.
|
| [22] |
Cao J, Gaamouch FE, Meabon JS, et al. ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury[J]. Sci Rep, 2017, 7(1): 11372.
|
| [23] |
Alexander S, Kerr ME, Kim Y, et al. Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury [J]. J Neurotrauma, 2007, 24(5): 790-797.
|
| [24] |
Asaro A, Carlo-Spiewok AS, Malik AR, et al. Apolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signaling[J]. Alzheimers Dement, 2020, 16(9): 1248-1258.
|
| [25] |
Zhang HL, Mao XJ, Zhang XM, et al. APOE epsilon3 attenuates experimental autoimmune neuritis by modulating T cell, macrophage and Schwann cell functions[J]. Exp Neurol, 2011, 230(2): 197-206.
|
| [26] |
Zhong J, Cheng C, Liu H, et al. Bexarotene protects against traumatic brain injury in mice partially through apolipoprotein E[J]. Neuroscience, 2017, 343: 434-448.
|
| [27] |
LoBue C, Woon FL, Rossetti HC, et al. Traumatic brain injury history and progression from mild cognitive impairment to Alzheimer disease[J]. Neuropsychology, 2018, 32(4): 401-409.
|
| [28] |
Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches[J]. Lancet Neurol, 2021, 20(1): 68-80.
|
| [29] |
Deng H, Ordaz A, Upadhyayula PS, et al. Apolipoprotein E epsilon 4 genotype, mild traumatic brain injury, and the development of chronic traumatic encephalopathy[J]. Med Sci (Basel), 2018, 6(3): 78.
|
| [30] |
Buchanan MM, Hutchinson M, Watkins LR, et al. Toll-like receptor 4 in CNS pathologies[J]. J Neurochem, 2010, 114(1): 13-27.
|
| [31] |
Corrigan F, Mander KA, Leonard AV, et al. Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation[J]. J Neuroinflammation, 2016, 13(1): 264.
|
| [32] |
Blackman JA, Worley G, Strittmatter WJ. Apolipoprotein E and brain injury: implications for children[J]. Dev Med Child Neurol, 2005, 47(1): 64-70.
|
| [33] |
Ponsford J, McLaren A, Schönberger M, et al. The association between apolipoprotein E and traumatic brain injury severity and functional outcome in a rehabilitation sample[J]. J Neurotrauma, 2011, 28(9): 1683-1692.
|
| [34] |
Li L, Bao Y, He S, et al. The association between apolipoprotein E and functional outcome after traumatic brain injury: a meta-analysis[J]. Medicine (Baltimore), 2015, 94(46): e2028.
|
| [35] |
Namjoshi DR, Martin G, Donkin J, et al. The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E[J]. PLoS One, 2013, 8(1): e53529.
|
| [36] |
Cao F, Jiang Y, Wu Y, et al. Apolipoprotein E-mimetic COG1410 reduces acute vasogenic edema following traumatic brain injury[J]. J Neurotrauma, 2016, 33(2): 175-82.
|
| [37] |
Wang C, Najm R, Xu Q, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector[J]. Nat Med, 2018, 24(5): 647-657.
|